Your browser doesn't support javascript.
loading
Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma.
Carrera, Caty; Cárcel-Márquez, Jara; Cullell, Natalia; Torres-Águila, Nuria; Muiño, Elena; Castillo, José; Sobrino, Tomás; Campos, Francisco; Rodríguez-Castro, Emilio; Llucià-Carol, Laia; Millán, Mònica; Muñoz-Narbona, Lucía; López-Cancio, Elena; Bustamante, Alejandro; Ribó, Marc; Álvarez-Sabín, José; Jiménez-Conde, Jordi; Roquer, Jaume; Giralt-Steinhauer, Eva; Soriano-Tárraga, Carolina; Mola-Caminal, Marina; Vives-Bauza, Cristófol; Navarro, Rosa Díaz; Tur, Silvia; Obach, Victor; Arenillas, Juan Francisco; Segura, Tomás; Serrano-Heras, Gemma; Martí-Fàbregas, Joan; Delgado-Mederos, Raquel; Freijo-Guerrero, M Mar; Moniche, Francisco; Cabezas, Juan Antonio; Castellanos, Mar; Gallego-Fabrega, Cristina; González-Sanchez, Jonathan; Krupinsky, Jurek; Strbian, Daniel; Tatlisumak, Turgut; Thijs, Vincent; Lemmens, Robin; Slowik, Agnieszka; Pera, Johanna; Kittner, Steven; Cole, John; Heitsch, Laura; Ibañez, Laura; Cruchaga, Carlos; Lee, Jin-Moo; Montaner, Joan.
Afiliação
  • Carrera C; Neurovascular Research Laboratory, VHIR, Universitat Autònoma de Barcelona, Barcelona 08035, Spain.
  • Cárcel-Márquez J; Stroke Pharmacogenomics and Genetics, IIB-Sant Pau, Barcelona 08025, Spain.
  • Cullell N; Stroke Pharmacogenomics and Genetics, IIB-Sant Pau, Barcelona 08025, Spain.
  • Torres-Águila N; Stroke Pharmacogenomics and Genetics, IIB-Sant Pau, Barcelona 08025, Spain.
  • Muiño E; Stroke Pharmacogenomics and Genetics, Fundació Docència i Recerca Mútua Terrassa, Terrassa 08221, Spain.
  • Castillo J; Stroke Pharmacogenomics and Genetics, IIB-Sant Pau, Barcelona 08025, Spain.
  • Sobrino T; Stroke Pharmacogenomics and Genetics, Fundació Docència i Recerca Mútua Terrassa, Terrassa 08221, Spain.
  • Campos F; Stroke Pharmacogenomics and Genetics, IIB-Sant Pau, Barcelona 08025, Spain.
  • Rodríguez-Castro E; Clinical Neurosciences Research Laboratory, IDIS, Santiago de Compostela, 15706, Spain.
  • Llucià-Carol L; Clinical Neurosciences Research Laboratory, IDIS, Santiago de Compostela, 15706, Spain.
  • Millán M; Clinical Neurosciences Research Laboratory, IDIS, Santiago de Compostela, 15706, Spain.
  • Muñoz-Narbona L; Department of Neurology, CHUS, Santiago de Compostela, 15706, Spain.
  • López-Cancio E; Stroke Pharmacogenomics and Genetics, IIB-Sant Pau, Barcelona 08025, Spain.
  • Bustamante A; Department of Neuroscience, HUGTP, Badalona 08916, Spain.
  • Ribó M; Department of Neuroscience, HUGTP, Badalona 08916, Spain.
  • Álvarez-Sabín J; Stroke Unit, HUCA, Oviedo 33011, Spain.
  • Jiménez-Conde J; Neurovascular Research Laboratory, VHIR, Universitat Autònoma de Barcelona, Barcelona 08035, Spain.
  • Roquer J; Stroke Unit, HUVH, Barcelona 08035, Spain.
  • Giralt-Steinhauer E; Department of Neurology, HUVH, UAB, Barcelona 08035, Spain.
  • Soriano-Tárraga C; Department of Neurology, Neurovascular Research Group, IMIM-Hospital del Mar, Barcelona 08003, Spain.
  • Mola-Caminal M; Department of Neurology, Neurovascular Research Group, IMIM-Hospital del Mar, Barcelona 08003, Spain.
  • Vives-Bauza C; Department of Neurology, Neurovascular Research Group, IMIM-Hospital del Mar, Barcelona 08003, Spain.
  • Navarro RD; Department of Neurology, Neurovascular Research Group, IMIM-Hospital del Mar, Barcelona 08003, Spain.
  • Tur S; Department of Neurology, Neurovascular Research Group, IMIM-Hospital del Mar, Barcelona 08003, Spain.
  • Obach V; Neurobiology Laboratory, IdISPa, Mallorca 07120, Spain.
  • Arenillas JF; Department of Neurology, HUSE, Mallorca 07120, Spain.
  • Segura T; Department of Neurology, HUSE, Mallorca 07120, Spain.
  • Serrano-Heras G; Department of Neurology, Hospital Clínic i Provincial de Barcelona, Barcelona 08036, Spain.
  • Martí-Fàbregas J; Department of Neurology, Hospital Clínico Universitario, University of Valladolid, Valladolid 47003, Spain.
  • Delgado-Mederos R; Department of Neurology, CHUA, Albacete 02006, Spain.
  • Freijo-Guerrero MM; Experimental Research Unit, CHUA, Albacete 02006, Spain.
  • Moniche F; Department of Neurology, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona 08025, Spain.
  • Cabezas JA; Department of Neurology, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona 08025, Spain.
  • Castellanos M; Neurovascular Unit, Biocruces Bizkaia Health Research Institute, Bilbao 48903, Spain.
  • Gallego-Fabrega C; Department of Neurology, Virgen del Rocío, IBIS, Seville 41023, Spain.
  • González-Sanchez J; Department of Neurology, Virgen del Rocío, IBIS, Seville 41023, Spain.
  • Krupinsky J; Department of Neurology, CHUAC, A Coruña 15006, Spain.
  • Strbian D; Stroke Pharmacogenomics and Genetics, IIB-Sant Pau, Barcelona 08025, Spain.
  • Tatlisumak T; Stroke Pharmacogenomics and Genetics, Fundació Docència i Recerca Mútua Terrassa, Terrassa 08221, Spain.
  • Thijs V; Stroke Pharmacogenomics and Genetics, Fundació Docència i Recerca Mútua Terrassa, Terrassa 08221, Spain.
  • Lemmens R; School of Healthcare Science, Manchester Metropolitan University, Manchester M15 6BH, UK.
  • Slowik A; School of Healthcare Science, Manchester Metropolitan University, Manchester M15 6BH, UK.
  • Pera J; Neurology Unit, Hospital Universitari Mútua Terrassa, Terrassa 08221, Spain.
  • Kittner S; Department of Neurology, Helsinki University Hospital, Helsinki FI-00029, Finland.
  • Cole J; Sahlgrenska Academy at University of Gothenburg and Sahlgrenska University Hospital, Gothenburg 41345, Sweden.
  • Heitsch L; Stroke Division, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Heidelberg, VIC 3072, Australia.
  • Ibañez L; Department of Neurology, Austin Health, Heidelberg, VIC 3072, Australia.
  • Cruchaga C; Department of Neurology, University Hospitals Leuven, Campus Gasthuisberg, Leuven 3000, Belgium.
  • Lee JM; Department of Neurology, Jagiellonian University Medical College, Kraków 31-007, Poland.
  • Montaner J; Department of Neurology, Jagiellonian University Medical College, Kraków 31-007, Poland.
Brain ; 144(8): 2416-2426, 2021 09 04.
Article em En | MEDLINE | ID: mdl-33723576
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Terapia Trombolítica / Hemorragia Cerebral / Ativador de Plasminogênio Tecidual / Polimorfismo de Nucleotídeo Único / AVC Isquêmico Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Brain Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Terapia Trombolítica / Hemorragia Cerebral / Ativador de Plasminogênio Tecidual / Polimorfismo de Nucleotídeo Único / AVC Isquêmico Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Brain Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha